Ankylosing Spondylitis References

Last updated: 23 April 2024
Reviewed by
  1. Keith MP. Overview of drug therapy for spondyloarthritis. Rheumatol Curr Res. 2013;3:119. http://omicsonline.org/overview-of-drug-therapy-for-spondyloarthritis-2161-1149.1000119.pdf.
  2. Ward MM, Deodhar A, Akl EA, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016 Feb;68(2):282-298. doi: 10.1002/art.39298. Accessed 27 May 2016. PMID: 26401991
  3. Van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Accessed 14 Jun 2021. PMID: 28087505
  4. Yu DT. Assessment and treatment of ankylosing spondylitis in adults. UpToDate. https://www.uptodate.com. May 2018. Accessed 22 Nov 2018.
  5. Yu DT, van Tubergen A. Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults. UpToDate. https://www.uptodate.com. 09 Jan 2020. Accessed 22 Nov 2018.
  6. ClinicalKey. Clinical overview: ankylosing spondylitis. ClinicalKey. http://www.clinicalkey.com. 30 October 2020.
  7. Inman RD. The spondyloarthropathies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020. http://www.clinicalkey.com. Accessed 11 Jun 2021:1718-1725e3.
  8. National Institute for Health and Care Excellence (NICE). Spondyloarthritis. NICE. http://www.nice.org.uk/. 28 Jun 2018. Accessed 14 Jun 2021.
  9. Tam LS, Wei JC, Aggarwal A, et al. 2018 APLAR axial spondyloarthritis treatment recommendations. Int J Rheum Dis. 2019 Mar;22(3):340-356. doi: 10.1111/1756-185X.13510. PMID: 30816645
  10. Ward MM, Deodhar A, Gensler LS, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285-1299. doi: 10.1002/acr.24025. Accessed 14 Jun 2021. PMID: 31436026
  11. Klavdianou K, Tsiami S, Baraliakos X. New developments in ankylosing spondylitis-status in 2021. Rheumatology (Oxford). 2021 Dec 24;60(Suppl 6):vi29-vi37. doi: 10.1093/rheumatology/keab523. PMID: 34951921
  12. Van der Heijde D, Baraliakos X, Sieper J, et al. POS0306 Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: a double-blind, randomized, placebo-controlled phase 3 trial. Annals of the Rheumatic Diseases. 2022;81:402-403. https://ard.bmj.com.
  13. U.S. Food & Drug Administration (US FDA). Abrilada highlights of prescribing information. US FDA. https://www.fda.gov/. Nov 2019. Accessed 18 Aug 2022.
  14. Forster D, Warburton L, O'Flynn N. Diagnosis and management of spondyloarthritis in the over-16s: NICE guideline. Br J Gen Pract. 2018 Jul;68(672):346-347. doi: 10.3399/bjgp18X697865. PMID: 29954812
  15. Mease P, Deodhar A. Differentiating nonradiographic axial spondyloarthritis from its mimics: A narrative review. BMC Musculoskelet Disord. 2022 Mar;23(1):240. doi: 10.1186/s12891-022-05073-7. PMID: 35279103
  16. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Ankylosing Spondylitis. NIH. https://www.niams.nih.gov/. May 2023.
  17. Navarro-Compán V, Boel A, Boonen A. The ASAS core measurement set for axial spondyloarthritis. Annals of Rheumatic Diseases. 2022;81:96-96. doi: 10.1136/annrheumdis-2022-eular.1798.
  18. Poddubnyy D. Classification vs diagnostic criteria: The challenge of diagnosing axial spondyloarthritis. Rheumatology. 2020 Oct;59(4):iv6-iv17. https://doi.org/10.1093/rheumatology/keaa250.
  19. Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023 Jan;82(1):19-34. doi: 10.1136/ard-2022-223296.
  20. Watson S. JAK inhibitors for ankylosing spondylitis. WebMD. https://www.webmd.com/.
  21. Yu D, Tubergen A. Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults. UpToDate. https://www.uptodate.com/. Jul 2023.
  22. Bautisa-Molano W, Fernández-Ávila DG, Brance ML, et al. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nat Rev Rheumatol. 2023 Nov;19(11):724-737. doi: 10.1038/s41584-023-01034-z. PMID: 37803079
  23. van Tubergen A. Treatment of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults. UpToDate. https://www.uptodate.com/. 22 Jan 2024.